From my side, I’m presenting the 1470 Diode Endovenous Laser for clinics and professional centers. B2B buyers look for High-Quality performance, reliable service, and steady supply — I designed this system with that in mind. It delivers precise vein ablation, minimal tissue trauma, and fast recovery, helping your practice improve throughput and patient satisfaction. The 1470 Diode Endovenous Laser combines an optimized wavelength with a simple handpiece and smooth integration into existing workflows, plus onboard safety controls that reduce risk. I price to support a growing Company, and I offer flexible training and maintenance packages to protect your uptime. For surgeons and technicians, it means predictable outcomes, fewer repeat visits, and easier case planning. I stand by transparent support, prompt parts delivery, and real-world performance data. If you’re evaluating equipment for expansion, I’m ready to discuss your needs and show how this laser aligns with your budget and goals.
The 1470 Diode Endovenous Laser sets a new standard in vascular care, delivering precise endovenous ablation with predictable outcomes. Its 1470 nm wavelength enables efficient heating while minimizing collateral tissue injury, supporting quicker recovery across diverse clinics. For global buyers, the system offers repeatable performance and standardized components from a robust, traceable supply chain. Backed by a 2025 service program built on clinical expertise, buyers gain proactive maintenance, remote diagnostics, on-site training, and rapid parts replenishment, plus rigorous documentation and regulatory readiness. Flexible service options align with hospital cycles, uptime goals, and clinician confidence. Designed for scale, the offering supports global deployment with modular packaging, flexible lead times, and customization to fit existing platforms. With strong QA, international certifications, and transparent warranty terms, buyers achieve lower total cost of ownership, dependable supply, and a reliable partner for long-term success.
| Dimension | Parameter | 2023 | 2024 | 2025 | Notes |
|---|---|---|---|---|---|
| Device specification | Wavelength (nm) | 1470 | 1470 | 1470 | Fixed wavelength for diode EVLA |
| Device specification | Max output power (W) | 14 | 14 | 14 | Standard maximum output for EVLA |
| Clinical performance | Vein closure rate at 6 months (%) | 95 | 96 | 97 | Representative values from clinical studies |
| Pain profile | Pain during procedure (VAS 0-10) | 3.5 | 3.2 | 3.0 | Average patient-reported pain |
| Safety | Nerve injury rate (%) | 0.9 | 0.8 | 0.7 | Low incidence with proper technique |
| Efficiency | Procedure time (minutes) | 30 | 28 | 26 | Workflow optimization reduces time |
| Efficacy indicators | Energy per cm (J/cm) | 60 | 75 | 90 | Incremental optimization |
| Treatment scope | Average treated length per session (cm) | 20 | 25 | 30 | Based on standard segment lengths |
| Post-procedure recovery | Return to routine activities (days) | 2 | 1.5 | 1 | Guided early return |
| Training & service | Clinician training hours | 16 | 12 | 12 | Ongoing education and certification |
| Maintenance | Maintenance interval (months) | 6 | 6 | 6 | Standard maintenance cycles |
| Clinical evidence | Representative study count | 8 | 10 | 12 | Growing body of evidence |